Answers are grounded in this paper and cite their sources.
Background: Metastatic prostate cancer is a global health challenge and requires a balanced approach to preserve the quality of life and extend survival. Current treatment is to offer monotherapy either orchidectomy or GnRH agonists or antagonists to hormone-sensitive metastatic prostate cancer patients. Androgen deprivation therapy increases the risk of obesity, diabetes, dyslipidemia and osteoporosis. Objectives: This study was done to compare the metabolic and cardiovascular impact of GnRH agonist and orchidectomy for androgendeprivation therapy in metastatic carcinoma prostate. Methods: This Quasi-experimental study was conducted at the Department of Urology, Dhaka Medical College Hospital, Dhaka during the period from July 2019 to December 2020. A total of 28 patients diagnosed with metastatic prostate cancer were included in the study as per inclusion and exclusion criteria. After counselling, patients were allocated to orchidectomy (Group- A) or GnRH agonist (group-B) as per the patient’s choice. After undergoing orchidectomy or receiving GnRH agonists, patients were advised to follow up at 1, 3 and 6 months. Two patients were lost to follow-up. Result: The mean age of patients in group-A was 66.55(range 58-74) years and in group B was67.8 (62-73) years. There was a significant increase in RBS, triglyceride and a decrease in HDL and bone mineral density at 6 months of group B compared to Group-A. After 6 months, 9.09% of patients in group-A compared to 26.6% of patients in group B had RBS above 11.1 mmol/L. In group-A, 45.45% of patients had triglyceride levels>150 mg/dL compared to 80% in group B. HDL level decreased <40 mg/dL in 45.45% of patients in group-A but 60% in group B. Bone mineral density decreased below -2.5 in 9.09% of patients in group- A compared to 46.66% in group B. Mean S.PSA was around 2 ng/ml in both groups during the follow-up period. The cardiovascular and metabolic impact of orchidectomy was less compared to GnRH agonists. .......
No takes yet. Share an insight, caveat, or question.
Mazumdar et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: